XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows From Operating Activities    
Net loss $ (15,103,722) $ (5,326,724)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 844,091 974,164
Bad debt (recovery) expense (85,535) 175,463
Impairment expense 24,881 0
Loss on shares issued in settlement of consulting agreement 152,629 0
Loss or (gain) on debt settlement 8,521,149 (178,749)
Equity based compensation expense 5,076,167 1,106,460
Loss on fair value of marketable securities 246,532 0
(Gain) on assets sale (1,763,430) 0
Change in fair value of warrant liability (72,755) 0
Amortization of debt discount and debt costs 177,072 1,212,006
Factoring discount fee and interest 0 20,480
Changes in assets and liabilities:    
Decrease (increase) in accounts receivable 451,844 (99,801)
Increase (decrease) in prepaid expenses and other current assets 99,101 (684)
Increase in accounts payable and accrued liabilities (230,885) 277,632
(Decrease) increase in deferred revenue (44,431) (32,696)
Net cash (used) in operating activities (1,707,292) (1,872,449)
Cash Flows From Investing Activities:    
Proceeds from sale of assets 1,763,430 0
Net cash provided by investing activities 1,763,430 0
Cash Flows From Financing Activities:    
Proceeds from ERC advances 0 450,000
Repayment of ERC advances 0 (450,000)
Issuance of common stock, net of fees 2,230,975 785,509
Payments of promissory notes (592,057)  
Repayments of notes (1,071,552) (495,473)
Proceeds from factoring agreement 0 871,821
Repayments of factoring agreement 0 (175,127)
Purchase of preferred shares pursuant to recapitalization 0 (80,000)
Gross proceeds from exercise of warrants 592,057 315,178
Net cash provided by financing activities 1,159,423 1,221,908
Net increase (decrease) in cash 1,215,561 (650,541)
Cash, beginning of period 1,008,408 946,804
Cash, end of period 2,223,969 296,263
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest 150,461 256,552
Cash paid during the period for income taxes 0 0
Supplemental schedule of non-cash investing and financing activities:    
Accounts receivable owed under factoring agreement collected directly by factor 0 1,000,020
Debt discount on warrants granted with notes 0 600,000
Debt issuance costs accrued 0 50,000
Deemed dividends 0 503,643
Offering costs as a result of modification of warrants to induce exercise 0 10,400
Issuance of common stock issued upon purchase of intangible assets 647,055 0
Warrants issued in connection with purchase of intangible assets 480,358 0
Issuance of common stock issued upon conversion of note payable 273,673 0
Issuance of common stock from conversion of Preferred stock, Series E 9 0
Issuance of common stock upon exercise of warrants and conversion of debt 1,115,437 0
Issuance of common stock for debt settlements $ 11,029,647 $ 0